纳洛酮逆转可乐定毒性:剂量、剂量、剂量
本研究为回顾性描述性队列,纳入52例6个月至16岁可乐定暴露的儿科患者。最常见表现为镇静(51例)、心动过缓(44例)和低血压(11例)。51例嗜睡患者中纳洛酮使40例苏醒;20例嗜睡伴心动过缓患者接受10 mg纳洛酮静脉推注,13例苏醒。作者结论认为高剂量纳洛酮(10 mg)可考虑用于所有可乐定中毒儿童,以避免因嗜睡而行气管插管。
要点
- 51例嗜睡患儿中纳洛酮使40例苏醒,其中5例有共同摄入物。
- 20例嗜睡伴心动过缓患者(11例小于3岁)接受10 mg纳洛酮静脉推注,13例苏醒,6例苏醒后心动过缓持续。
- 其余31例中22例在纳洛酮6 mg或更少剂量后苏醒;11例低血压患者中7例血压被逆转。
- 任何剂量纳洛酮后均无不良事件,包括21例接受10 mg纳洛酮的患者。
- 作者认为可乐定中毒的并发症可能源于气管插管,高剂量纳洛酮(10 mg)可考虑用于所有可乐定中毒儿童。
适用人群与场景
- 6个月至16岁因可乐定暴露就诊的儿科患者,来自医院病历回顾。
处置流程与药物剂量
- 20例嗜睡伴心动过缓患者接受10 mg纳洛酮静脉推注,其中13例苏醒。
- 其余31例中22例在纳洛酮6 mg或更少剂量后苏醒。
- 9例患者出现复发性镇静,经重复纳洛酮推注后缓解。
- 11例低血压患者中7例血压被纳洛酮逆转;仅1例低血压患者(有共同摄入物)因低血压接受血管升压药。
- 3例清醒且血压正常的患者因心动过缓接受血管升压药。
- 7例患者纳洛酮后苏醒且生命体征正常,但因转运接受化学镇静和气管插管。
红旗征与不能漏的情况
- 嗜睡(51例)是需要识别的主要表现,纳洛酮可使其苏醒。
- 心动过缓(44例)和低血压(11例)常见;持续心动过缓被描述为良性,低血压被描述为罕见且无临床意义。
研究设计与关键结果
- 回顾性描述性队列纳入52例6个月至16岁可乐定暴露的儿科患者,最常见表现为镇静(51例)、心动过缓(44例)和低血压(11例)。
- 51例嗜睡患者中纳洛酮使40例苏醒,其中5例有共同摄入物;9例出现复发性镇静,重复纳洛酮推注后缓解。
- 20例嗜睡伴心动过缓患者(11例小于3岁)接受10 mg纳洛酮静脉推注,13例苏醒,6例苏醒后心动过缓持续。
- 其余31例中22例在纳洛酮6 mg或更少剂量后苏醒;11例低血压患者中7例血压被逆转。
- 仅1例低血压患者(有共同摄入物)因低血压接受血管升压药;3例清醒且血压正常的患者因心动过缓接受血管升压药。
- 7例患者纳洛酮后苏醒且生命体征正常,但因转运接受化学镇静和气管插管。任何剂量纳洛酮后均无不良事件。
证据类型、等级与局限
- 证据类型:回顾性描述性队列(经IRB批准)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,高剂量纳洛酮(10 mg)可考虑用于所有可乐定中毒儿童,以避免因嗜睡而行气管插管。
- 作者认为,该中毒的并发症可能源于气管插管,而高剂量纳洛酮(10 mg)可能预防该操作。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Following clonidine ingestion, naloxone is seldom administered as it is considered ineffective in reversing somnolence, bradycardia, or hypotension. However, this conclusion has been based on administration of small doses (2 mg or less) of naloxone. The somnolence is frequently treated with endotracheal intubation (ETI), a procedure with significant morbidity.
OBJECTIVE: We aimed to determine if naloxone administration reversed the effects of clonidine or caused any adverse effects.
METHODS: We performed a retrospective descriptive cohort (IRB approved) of hospital medical records for pediatric patients (6 months-16 years) with clonidine exposure. Demographics, history, co-ingestants, clinical data, treatments, and outcome were recorded in a de-identified database.
RESULTS: The most common clinical findings in the 52 patients were sedation (n = 51), bradycardia (n = 44), and hypotension (n = 11). Of 51 somnolent patients, naloxone administration awoke 40 patients, five of which had co-ingestants. Nine patients experienced recurrent sedation that resolved with a repeat bolus of naloxone. Twenty somnolent bradycardic patients (11 less than 3 years old) received 10 mg naloxone via intravenous bolus. Thirteen awoke; bradycardia persisted in six of the awake patients. Of the remaining 31 patients, 22 awoke following 6 mg or less of naloxone. Naloxone reversed hypotension in 7 of 11 hypotensive patients. Only one hypotensive patient (with a coingestion) received vasopressors for hypotension. Three awake normotensive patients received vasopressors for bradycardia. Seven patients awoke and had normal vital signs following naloxone administration, but were chemically sedated and intubated for transport. There were no adverse events following the administration of any dose of naloxone.
CONCLUSIONS: Administration of naloxone to somnolent pediatric patients with clonidine toxicity awoke the majority (40/51) and resolved bradycardia and hypotension in some. Persistent bradycardia was benign. Hypotension was rare and clinically insignificant. No adverse effects occurred in any patient including the 21 patients who received 10 mg naloxone. Morbidity in this overdose may be due to ETI, a procedure that could be prevented if high-dose naloxone (10 mg) were administered. Administration of high-dose naloxone should be considered in all children with clonidine toxicity.
参考来源
- Seger DL, Loden JK. Naloxone reversal of clonidine toxicity: dose, dose, dose. Clin Toxicol (Phila). 2018. PMID: 29544366. doi:10.1080/15563650.2018.1450986
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。